Sanna Sillankorva

Dr. Sanna Sillankorva

INL - International Iberian Nanotechnology Laboratory, Braga, Portugal
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2016 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
DPDiana Pires
Diana Pires
Hugo OliveiraHugo Oliveira
Hugo Oliveira
Luís D. R. MeloLuís D. R. Melo
Luís D. R. Melo
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
JAJoana Azeredo
Joana Azeredo

1 September 2016 in Microbiology and Molecular Biology Reviews
Verified
Journal Article
Open access
PDF file
DPDiana Pires
Diana Pires
SCSara Cleto
Sara Cleto
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
JAJoana Azeredo
Joana Azeredo
TLTimothy K. Lu
Timothy K. Lu
SUMMARY Soon after their discovery in the early 20th century, bacteriophages were recognized to have great potential as antimicrobial agents, a potential that has yet to be fully realized. The nascent field of phage therapy was adversely affected by inadequately controlled trials and the discovery of antibiotics. Although the study of phages as anti-infective agents slowed, phages played an important role in the development of molecular biology. In recent years, the increase in multidrug-resistant bacteria has renewed interest in the use of phages as antimicrobial agents. With the wide array of possibilities offered by genetic engineering, these bacterial viruses are being modified to precisely control and detect bacteria and to serve as new sources of antibacterials. In applications that go beyond their antimicrobial activity, phages are also being developed as vehicles for drug delivery and vaccines, as well as for the assembly of new materials. This review highlights advances in techniques used to engineer phages for all of these purposes and discusses existing challenges and opportunities for future work.

1 October 2017 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
DPDp Pires
Dp Pires
LMLdr Melo
Ldr Melo
DBDiana Vilas Boas
Diana Vilas Boas
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
JAJoana Azeredo
Joana Azeredo

1 August 2018 in Food Hydrocolloids
Verified
Journal Article
Closed access
MCMaria J. Costa
Maria J. Costa
AMArlete M. Marques
Arlete M. Marques
Lorenzo  M. PastranaLorenzo M. Pastrana
Lorenzo M. Pastrana
José TeixeiraJosé Teixeira
José Teixeira
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
MCMiguel A. Cerqueira
Miguel A. Cerqueira

18 December 2012 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
Hugo OliveiraHugo Oliveira
Hugo Oliveira
JAJoana Azeredo
Joana Azeredo
The interest for natural antimicrobial compounds has increased due to alterations in consumer positions towards the use of chemical preservatives in foodstuff and food processing surfaces. Bacteriophages fit in the class of natural antimicrobial and their effectiveness in controlling bacterial pathogens in agro-food industry has led to the development of different phage products already approved by USFDA and USDA. The majority of these products are to be used in farm animals or animal products such as carcasses, meats and also in agricultural and horticultural products. Treatment with specific phages in the food industry can prevent the decay of products and the spread of bacterial diseases and ultimately promote safe environments in animal and plant food production, processing, and handling. This is an overview of recent work carried out with phages as tools to promote food safety, starting with a general introduction describing the prevalence of foodborne pathogens and bacteriophages and a more detailed discussion on the use of phage therapy to prevent and treat experimentally induced infections of animals against the most common foodborne pathogens, the use of phages as biocontrol agents in foods, and also their use as biosanitizers of food contact surfaces.

7 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Hugo OliveiraHugo Oliveira
Hugo Oliveira
Viruthachalam ThiagarajanViruthachalam Thiagarajan
Viruthachalam Thiagarajan
MWMaarten Walmagh
Maarten Walmagh
Sanna SillankorvaSanna Sillankorva
Sanna Sillankorva
Rob LavigneRob Lavigne
Rob Lavigne
JAJoana Azeredo
Joana Azeredo
Resistance rates are increasing among several problematic Gram-negative pathogens, a fact that has encouraged the development of new antimicrobial agents. This paper characterizes a Salmonella phage endolysin (Lys68) and demonstrates its potential antimicrobial effectiveness when combined with organic acids towards Gram-negative pathogens. Biochemical characterization reveals that Lys68 is more active at pH 7.0, maintaining 76.7% of its activity when stored at 4°C for two months. Thermostability tests showed that Lys68 is only completely inactivated upon exposure to 100°C for 30 min, and circular dichroism analysis demonstrated the ability to refold into its original conformation upon thermal denaturation. It was shown that Lys68 is able to lyse a wide panel of Gram-negative bacteria (13 different species) in combination with the outer membrane permeabilizers EDTA, citric and malic acid. While the EDTA/Lys68 combination only inactivated Pseudomonas strains, the use of citric or malic acid broadened Lys68 antibacterial effect to other Gram-negative pathogens (lytic activity against 9 and 11 species, respectively). Particularly against Salmonella Typhimurium LT2, the combinatory effect of malic or citric acid with Lys68 led to approximately 3 to 5 log reductions in bacterial load/CFUs after 2 hours, respectively, and was also able to reduce stationary-phase cells and bacterial biofilms by approximately 1 log. The broad killing capacity of malic/citric acid-Lys68 is explained by the destabilization and major disruptions of the cell outer membrane integrity due to the acidity caused by the organic acids and a relatively high muralytic activity of Lys68 at low pH. Lys68 demonstrates good (thermo)stability properties that combined with different outer membrane permeabilizers, could become useful to combat Gram-negative pathogens in agricultural, food and medical industry.